Lopinavir/ritonavir population pharmacokinetics in neonates and infants.

What Is Already Known About This Subject: • Lopinavir/ritonavir pharmacokinetics have been fully investigated in adults and children.

What This Study Adds: • Lopinavir/ritonavir population pharmacokinetics in 96 neonates and infants from birth to less than 2 years (1.16 to 10.

Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children.

Background: Data on adherence to and acceptability of once daily lamivudine and abacavir are few.

Methods: Twenty-four U.K.